Back to top

Tale of the Tape

Zacks Equity Research

Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher

GERN ALXN CBM

Trades from $3
Read Full ArticleHide Full Article

Geron Corporation (GERN - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session.  This reverses the recent downtrend for the company as the stock is now down about 65% since Feb 27.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate has remained unchanged. However, the recent rally high is encouraging, so make sure to keep a close watch on this firm in the near future.

Geron Corporation currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN - Free Report) , with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. and Cambrex Corporation. (CBM - Free Report) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Geron Corporation (GERN) - free report >>

Alexion Pharmaceuticals, Inc. (ALXN) - free report >>

Cambrex Corporation (CBM) - free report >>